DXCMDexcom
We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world. 10-K, Item 1
- Employees
- 11,100
- Headquarters
- San Diego, CA
- CEO
- Jacob Steven Leach
- Next results
- around Jan 11, 2027
From 2021 to 2025, CEO pay as reported rose 102% while net income rose 286%. $100 in the shares at the start of the table was worth $72 at the end (peer group: $79). CEO pay over the 5 years: $83.2M.
| Fiscal year to | CEO | CEO pay (reported) | CEO pay (actually paid) | Other executives, average | $100 became | Peer group | Net income | Company measure |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | - | $24.3M | $19.7M | $6.6M | $72 | $79 | $836.3M | $4.6B |
| Dec 31, 2024 | - | $15.8M | -$8.7M | $5.6M | $84 | $79 | $576.2M | $4.0B |
| Dec 31, 2023 | - | $15.7M | $23.0M | $5.0M | $134 | $75 | $541.5M | $3.6B |
| Dec 31, 2022 | - | $15.4M | $5.7M | $4.4M | $123 | $79 | $341.2M | $3.0B |
| Dec 31, 2021 | - | $12.0M | $36.1M | $5.0M | $145 | $104 | $216.9M | $2.4B |
Pay versus performance table of the proxy statement (DEF 14A) filed Apr 15, 2026, as tagged by the company in XBRL. Open the proxy ↗
Work on DXCM in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/DXCM/export.csv") into a cell.